97349663 - THE WORLD'S COVID-19 VACCINE TEXAS CHILDREN'S HOSPITAL

Information

• Trademark
• 97349663

• Source

• Serial Number

  97349663

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 25 - Clothing, footwear, headgear
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  April 06, 2022
  2 years ago

• Transaction Date

  November 17, 2024
  3 months ago

• Status Date

  March 04, 2024
  a year ago

• Published for Opposition Date

  June 06, 2023
  a year ago

• Location Date

  August 01, 2023
  a year ago

• Status Code

  606

• Current Location

  INTENT TO USE SECTION

  Employee Name

  SALES, HEATHER

• Attorney Docket Number

  TXCH.T0115US

  Attorney Name

  James W. Repass

  Law Office Assigned Location Code

  N40

• Owners

  • TEXAS CHILDREN'S HOSPITAL

Case File Statements

• DM0000: The mark consists of the words "THE WORLD'S COVID-19 VACCINE" written above the words "TEXAS CHILDREN'S HOSPITAL." "COVID-19" is in red letters. The "I" in COVID is an image of a syringe. A design in red comprised of a solid circle centered above three upwardly angled or curved lines of increasing length is adjacent to "TEXAS CHILDREN'S HOSPITAL". The rest of the lettering is in black. The white in the drawing is background areas only and not claimed as a feature of the mark.
• GS0051: COVID-19 vaccine preparations
• PM0001: THE WORLD'S COVID ONE NINE VACCINE TEXAS CHILDREN'S HOSPITAL, THE WORLD'S COVID NINETEEN VACCINE TEXAS CHILDREN'S HOSPITAL
• TF0000: as to TEXAS CHILDREN'S HOSPITAL
• GS0251: T-shirts, shirts, hats, baseball caps
• CC0000: The color(s) red and black is/are claimed as a feature of the mark.
• DS0000: "THE WORLD'S COVID-19 VACCINE" FOR INTERNATIONAL CLASSES 005 AND 044 AND "THE WORLD'S COVID-19 VACCINE TEXAS CHILDREN'S HOSPITAL" FOR INTERNATIONAL CLASS 025 APART FROM THE MARK AS SHOWN.
• GS0421: COVID-19 vaccine research and development; providing information about medical and scientific research in the field of vaccine development and the prevention and treatment of COVID-19

Case File Event Statements

• 4/9/2022 - 2 years ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 4/11/2022 - 2 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 4/12/2022 - 2 years ago

  3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSM

• 1/11/2023 - 2 years ago

  4 - ASSIGNED TO EXAMINER Type: DOCK

• 1/14/2023 - 2 years ago

  5 - NON-FINAL ACTION WRITTEN Type: CNRT

• 1/14/2023 - 2 years ago

  6 - NON-FINAL ACTION E-MAILED Type: GNRT

• 1/14/2023 - 2 years ago

  7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 4/14/2023 - a year ago

  8 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 4/14/2023 - a year ago

  9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 4/14/2023 - a year ago

  10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 5/1/2023 - a year ago

  11 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 5/1/2023 - a year ago

  12 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 5/1/2023 - a year ago

  13 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 5/1/2023 - a year ago

  14 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 5/4/2023 - a year ago

  15 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 5/17/2023 - a year ago

  16 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 6/6/2023 - a year ago

  17 - PUBLISHED FOR OPPOSITION Type: PUBO

• 6/6/2023 - a year ago

  18 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 8/1/2023 - a year ago

  19 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM

• 3/4/2024 - a year ago

  20 - ABANDONMENT - NO USE STATEMENT FILED Type: ABN6

• 3/4/2024 - a year ago

  21 - ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Type: MAB6